Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data.
about
Elevated CETP Lipid Transfer Activity is Associated with the Risk of Venous Thromboembolism.Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial.Lipid profile of platelets and platelet-derived microparticles in ovarian cancer.Metabolomic analysis of 92 pulmonary embolism patients from a nested case-control study identifies metabolites associated with adverse clinical outcomes.Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk.
P2860
Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Acylcarnitines are anticoagula ...... s, based on metabolomics data.
@ast
Acylcarnitines are anticoagula ...... s, based on metabolomics data.
@en
type
label
Acylcarnitines are anticoagula ...... s, based on metabolomics data.
@ast
Acylcarnitines are anticoagula ...... s, based on metabolomics data.
@en
prefLabel
Acylcarnitines are anticoagula ...... s, based on metabolomics data.
@ast
Acylcarnitines are anticoagula ...... s, based on metabolomics data.
@en
P2093
P2860
P50
P1433
P1476
Acylcarnitines are anticoagula ...... s, based on metabolomics data.
@en
P2093
Darlene J Elias
Ewa Kalisiak
Hiroshi Deguchi
José A Fernández
Linh Hoang
Minerva Tran
Subramanian Yegneswaran
P2860
P304
P356
10.1182/BLOOD-2015-03-636761
P407
P577
2015-07-14T00:00:00Z